HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krupp, L. B. Articles by Rizvi, S. A. Search for Related Content PubMed PubMed Citation Articles by Krupp, L. B. Articles by Rizvi, S. A.

Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology.

Symptomatic therapy for underrecognized manifestations of multiple sclerosis

From the Multiple Sclerosis Comprehensive Care Center, Stony Brook, NY.

Address correspondence and reprint requests to Dr. Lauren B. Krupp, State University of New York at Stony Brook, T12–20 Health Sciences Center, Stony Brook, NY 11794-8121.

The symptoms that affect individuals with MS are diverse and change over time. Addressing symptoms in a multidisciplinary fashion and helping patients address problems as they occur are the major elements of symptom management. Successful management involves treating not only the more readily recognized manifestations of MS but also the less apparent MS features, including fatigue, cognitive loss, mood disturbance, and pain. Management of these symptoms is reviewed.

This article has been cited by other articles:

				P. Flachenecker and H. Meissner Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment Multiple Sclerosis, March 1, 2008; 14(2): 274 - 277. [Abstract] [PDF]

				T Kumpfel, L A Hoffmann, W Pollmann, P Rieckmann, U K Zettl, R Kuhnbach, G D Borasio, and R Voltz Palliative care in patients with severe multiple sclerosis: two case reports and a survey among German MS neurologists Palliative Medicine, March 1, 2007; 21(2): 109 - 114. [Abstract] [PDF]

				R F Brown, C C Tennant, M Sharrock, S Hodgkinson, S M Dunn, and J D Pollard Relationship between stress and relapse in multiple sclerosis: part II. Direct and indirect relationships Multiple Sclerosis, August 1, 2006; 12(4): 465 - 475. [Abstract] [PDF]

				S L Minden, D Frankel, L Hadden, J Perloff, K P Srinath, and D C Hoaglin The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics Multiple Sclerosis, February 1, 2006; 12(1): 24 - 38. [Abstract] [PDF]

				L. V Kalia and P. W OConnor Severity of chronic pain and its relationship to quality of life in multiple sclerosis Multiple Sclerosis, June 1, 2005; 11(3): 322 - 327. [Abstract] [PDF]

				H. Crayton, R. A. Heyman, and H. S. Rossman A multimodal approach to managing the symptoms of multiple sclerosis Neurology, December 14, 2004; 63(11_suppl_5): S12 - S18. [Abstract] [Full Text]

				P. Flachenecker, I. Bihler, F Weber, M Gottschalk, K. V Toyka, and P. Rieckmann Cytokine mRNA expression in patients with multiple sclerosis and fatigue Multiple Sclerosis, April 1, 2004; 10(2): 165 - 169. [Abstract] [PDF]

				G Brichetto, M M. Uccelli, G L Mancardi, and C Solaro Symptomatic medication use in multiple sclerosis Multiple Sclerosis, October 1, 2003; 9(5): 458 - 460. [Abstract] [PDF]